Skip to content

An analyze of gene profiling of submucosal tumor (SMT) using biopsy sample

An analyze of gene profiling of submucosal tumor (SMT) using biopsy sample - An analyze of gene profiling of SMT for biopsy sample

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000031099
Enrollment
50
Registered
2018-02-01
Start date
2018-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Submucosal tumor of gastrointestine

Interventions

None listed

Sponsors

Kyushu Univercity
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who have SMT and undergo EUS-FNA or endoscopic mucosal incision assisted biopsy (MIAB). 2. Patients who are diagnosed as GIST or leyomioma. 3. Patients from whom written informed consent is obtained. 4. Patients who are older than 20 years old.

Exclusion criteria

Exclusion criteria: 1. Patients who are judged as contraindication for EUS-FNA or MIAB. 2.Patients who are judged as being inappropriate for this study by their medical doctor.

Design outcomes

Primary

MeasureTime frame
Relationship between gene expression and malignancy.

Countries

Japan

Contacts

Public ContactYosuke Minoda

Kyushu University Graduate School of Medical Sciences Department of Medicine and Bioregulatory Science

yminoda@med.kyushu-u.ac.jp092-642-5286

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026